Heartland Institute: President Trump's Pick to Lead FDA Offers Opportunity for Life-Saving Reforms
November 05, 2019
November 05, 2019
ARLINGTON HEIGHTS, Illinois, Nov. 5 -- The Heartland Institute issued the following news release:
We would all benefit if the new commissioner gives top priority to modernizing the FDA regulatory process in order to deliver on the primary objective of better drugs, sooner, at lower cost" - Bartley Madden
Dr. Stephen Hahn, a cancer specialist, said to be Trump's nominee for Commissioner of the Food and Drug Administration'
President Trump recently nomin . . .
We would all benefit if the new commissioner gives top priority to modernizing the FDA regulatory process in order to deliver on the primary objective of better drugs, sooner, at lower cost" - Bartley Madden
Dr. Stephen Hahn, a cancer specialist, said to be Trump's nominee for Commissioner of the Food and Drug Administration'
President Trump recently nomin . . .